Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress

Pharmazie

Volumn 69, Issue 1, 2014, Pages 64-69

  Cai, Huaiqiu ^a   Zhang, Gaigai ^b   Chen, Wenjia ^a   Zhang, Bo ^a   Zhang, Jinsheng ^c   Chang, Jinrui ^c   Tang, Chaoshu ^c   Qi, Yongfen ^c   Yin, Xinhua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b FIRST HOSPITAL OF TSINGHUA UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CASPASE 12; CEBP HOMOLOGOUS PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; METFORMIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HEART HEMODYNAMICS; HEART MUSCLE INJURY; HEART PROTECTION; HISTOPATHOLOGY; ISOPROTERENOL INDUCED MYOCARDIAL INJURY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MORTALITY; NONHUMAN; PROTEIN CLEAVAGE; RAT; UPREGULATION; WESTERN BLOTTING;

ADRENERGIC BETA-AGONISTS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARDIOTONIC AGENTS; ENDOPLASMIC RETICULUM STRESS; HEART DISEASES; HEMODYNAMICS; HYPOGLYCEMIC AGENTS; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; METFORMIN; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84893057004     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.3663     Document Type: Article

References (34)

1. Azfer A, Niu J, Rogers LM, Adamski FM, Kolattukudy PE (2006) Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am J Physiol Heart Circ Physiol 291: H1411- H1420. (Pubitemid 44343688)
2. Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, Yellon DM (2008) Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition poreopening. Basic Res Cardiol 103: 274-284.
3. Boyce M, Yuan J (2006) Cellular response to endoplasmic reticulum stress: A matter of life or death. Cell Death Differ 13: 363-373.
4. Chang L, Zhao J, Li GZ, Geng B, Pan CS, Qi YF, Tang CS (2004) Ghrelin protects myocardium from isoproterenol-induced injury in rats. Acta Pharmacol Sin 25: 1131-1137. (Pubitemid 39237403)
5. Davis BJ, Xie Z, Viollet B, ZouMH(2006) Activation of the AMP- activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55: 496-505. (Pubitemid 43343281)
6. DongY, Zhang M, Liang B, Xie Z, Zhao Z, Asfa S, Choi HC, ZouMH(2010) Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 121: 792-803.
7. Eindhoven JA, van den Bosch AE, Jansen PR, Boersma E, Roos-Hesselink JW (2012) The usefulness of brain natriuretic peptide in complex congenital heart disease: A systematic review. J Am Coll Cardiol 60: 2140-2149.
8. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C (2004) Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318: 756-763. (Pubitemid 38624219)
9. George I, Sabbah HN, Xu K, Wang N, Wang J (2011) -adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines. Cardiovasc Res 91: 447-455.
10. Gora S, Maouche S, Atout R, Wanherdrick K, Lambeau G, Cambien F, Ninio E, Karabina SA (2010) Phospholipolyzed LDL induces an inflammatory reponse in endothelial cells through endoplasmic reticulum stress signaling. FASEB J 24: 3284-3297.
11. Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D, Ramachandran A, Anaya-Cisneros M, Tian R, Lefer DJ (2009) Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res 104: 403-411.
12. Hamada H, Suzuki M, Yuasa S, Mimura N, Shinozuka N, Takada Y, Suzuki M, Nishino T, Nakaya H, Koseki H, Aoe T (2004) Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice. Mol Cell Biol 24: 8007-8017. (Pubitemid 39167451)
13. Jia YX, Yang JH, Pan CS, Geng B, Zhang J, Xiao Y, Zhao J, Gerns H, Yang J, Chang JK, Wen JK, Tang CS, Qi YF (2006) Intermedin1-53 protects the heart against isoproterenol-induced ischemic injury in rats. Eur J Pharmacol 549: 117-123. (Pubitemid 44441261)
14. JiangW, CaiDY, Pan CS, Qi YF, Jiang HF, Geng B, Tang CS (2005) Changes in production and metabolism of brain natriuretic peptide in rats with myocardial necrosis. Eur J Pharmacol 507: 153-162. (Pubitemid 40126851)
15. Kaufman RJ (2002) Orchestrating the unfolded protein response in health and disease. J Clin Invest 110: 1389-1398. (Pubitemid 35396907)
16. Kim DS, Jeong SK, Kim HR, Kim DS, ChaeSW, Chae HJ (2010) Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. Immunopharmacol Immunotoxicol 32: 251-257.
17. Liu XH, Zhang ZY, Sun S, Wu XD (2008) Ischemic postconditioning protects myocardium from ischemia/reperfusion injury through attenuating endoplasmic reticulum stress. Shock 30: 422-427.
18. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM(2005) Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 111: 583-590. (Pubitemid 40216485)
19. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators (2011) Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin- Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study. Diabetologia 54: 1308-1317.
20. Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306. (Pubitemid 15030720)
21. Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M (2009) Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation 119: 2568-2577.
22. SchröderM, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789. (Pubitemid 40995523)
23. Singal PK, Beamish RE, Dhalla NS (1983) Potential oxidative pathways of catecholamines in the formation of Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 161: 391-401.
24. Solskov L, Løfgren B, Kristiansen SB, Jessen N, Pold R, Nielsen TT, Bøtker HE, Schmitz O, Lund S (2008) Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration. Basic Clin Pharmacol Toxicol 103: 82-87. (Pubitemid 351874532)
25. Song JQ, Teng X, Cai Y, Tang CS, Qi YF (2009) Activation of Akt/GSK- 3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 14: 1299-1307.
26. Soraya H, Khorrami A, Garjani A, Maleki-Dizaji N, Garjani A (2012a) Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infraction in rats. Pharmacol Rep 64: 1476-1484.
27. Soraya H, Farajnia S, Khani S, Rameshrad M, Khorrami A, Banani A, Maleki-Dizaji N, GarjaniA(2012b) Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infraction in rat: are AMPK and TLRs connected? Int Immunopharmacol 14:785-791.
28. Teng X, Song J, Zhang G, Cai Y, Yuan F, Du J, Tang C, Qi Y (2011) Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway. J Mol Med 89: 1195-1205.
29. Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, Kawase I, Hirota H (2005) AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 25: 9554-9575. (Pubitemid 41507855)
30. Xin W, Lu X, Li X, Niu K, Cai J (2011) Attenuation of endoplasmic reticulum stress-related myocardial apoptosis by SERCA2a gene delivery in ischemic heart disease. Mol Med 17: 201-210.
31. Yeh CH, Chen TP, Wang YC, Lin YM, Fang SW (2010) AMPactivated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress. Mediators Inflamm 2010: 130636.
32. YinM, van der Horst IC, van Melle JP, Qian C, van Gilst WH, Silljé HH, de Boer RA (2011) Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. Am J Physiol Heart Circ Physiol 301: H459-H468.
33. Zhang GG, Teng X, Liu Y, Cai Y, Zhou YB, Duan XH, Song JQ, Shi Y, Tang CS, Yin XH, Qi YF (2009) Inhibition of endoplasm reticulum stress by ghrelin protects against ischemia/reperfusion injury in rat heart. Peptides 30: 1109-1116.
34. Zou MH, WuY(2008) AMP-activated protein kinase activation as a strategy for protectin vascular endothelial function. Clin Exp Pharmacol Physiol 35: 535-545.